Vibrio vulnificus produces Hemolysin/cytolysin (VvhA), which is one of the most potent exotoxins capable of killing mice at submicrogram levels. However, V. vulnificus growth and vvhA expression are severely repressed and extracellular VvhA produced at low levels is easily inactivated in human body fluids. This study was conducted to obtain additional unequivocal evidence of the enigmatic characteristic of VvhA. V. vulnificus growth was stimulated, vvhA expression was de-repressed, and extracellular VvhA production was increased in cirrhotic ascites, a human ex vivo experimental system, by a mutation of fur encoding ferric uptake regulator, which acts as a transcriptional repressor. However, regardless of the presence or absence of the fur mutation, extracellular VvhA activity was not detected in cirrhotic ascites. These results indicate that VvhA is easily inactivated even when vvhA expression and extracellular VvhA production are maintained at high levels in cirrhotic ascites.
INTRODUCTION
Vibrio vulnificus is a gram-negative halophilic bacterium capable of causing primary septicemia and necrotizing wound infections with a high mortality rate in susceptible individuals with underlying illnesses, especially hepatic diseases (1) .
V. vulnificus produces hemolysin or cytolysin (VvhA) as an exotoxin. Purified VvhA is so potent that it can kill mice at submicrogram levels (2) . However, its pathogenetic role remains enigmatic since vvhA mutations do not affect the virulence of V. vulnificus (3) . Recently, VvhA was reported to exhibit only minor cytotoxicity only in the absence of the major cytotoxic factor, RtxA1 (4) . From an evolutionary perspective, VvhA is currently considered to be only one of multiple factors capable of affecting the pathophysiological changes observed with V. vulnificus infections or the enhanced survival of V. vulnificus in environments or hosts (5~9).
Previous studies revealed that vvhA expression is severely repressed and even extracellular VvhA produced at low levels is easily inactivated in human body fluids, especially in cirrhotic ascites which is a useful human ex vivo experimental system (7, 8) . A recent in vitro study revealed that vvhA expression is repressed by iron and de-repressed by a mutation of the fur gene, which encodes a transcription repressor known as ferric uptake regulator (Fur); however, extracellular VvhA secretion via the PilD-mediated type II 91 general secretion system (PilD-mediated II-GSS) is increased by iron (9) . Whether vvhA expression in human body fluids may also be de-repressed by a fur mutation remains undetermined.
Generally, to elucidate the pathogenetic roles of a gene or its product, the gene is mutated or down-regulated. In contrast, alternate methods capable of up-regulating gene expression are required to elucidate the in vivo pathogenetic roles of gene products, particularly in cases where the genes are expressed at very low levels in human body fluids. Accordingly, to obtain further unequivocal evidence related to the enigmatic role of VvhA, we determined extracellular VvhA activity under the condition that vvhA expression and extracellular VvhA production were de-repressed at high levels in an ex vivo experimental model of cirrhotic ascites by a fur mutation.
MATERIALS AND METHODS

Bacterial strains, media, cirrhotic ascites, and reagents
The bacterial strains used in this study are listed in Table 1 .
Luria-Bertani medium (BD, Franklin Lakes, NJ, USA) and Thiosulfate-Citrate-Bile-Sucrose medium (BD) containing 20 μg/ml ampicillin, 300 μg/ml kanamycin, 2 μg/ml tetracycline or 2 μg/ml chloramphenicol were used for selection and subculture of recombinant strains. Heart Infusion (HI; BD) agar or broth containing additional 2.0% NaCl was used as the basal medium for cultivation of V. vulnificus strains. HI broth was deferrated using 8-hydroxyquinoline as described by Leong and Neilands (13) . The residual iron concentration of the deferrated HI broth was 1.0 μg/dl or less, which was measured as described by Stookey (14) .
However, V. vulnificus strains did not grow well in the deferrated HI broth due to the low iron concentration; therefore, 1.0 μM of ferric chloride was exogenously added to the broth. This medium could support V. vulnificus growth to some extent and was designated as an iron-deficient HI broth. Ascites samples were collected from five liver cirrhosis patients following their informed consent and approval of the study by the Institutional Review Board at Chosun University Hospital. Equal volumes of ascites samples were pooled to avoid individual variances and then prepared as described previously (8) . Unless noted otherwise, all reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Construction of transcription reporter strains
A β-galactosidase gene (lacZ)-deletion mutant strain (CMM2101) was constructed from M06-24/O with spontaneous streptomycin resistance as described previously (10, 11) . From CMM2101, a fur-deletion mutant strain (CMM2304) was constructed as we previously described (12) . The merozygotic P vvhA ::lacZ transcription reporter strains (CMM2103 with wild-type fur and CMM2305 with deleted fur) were constructed from CMM2101 and CMM-2304, respectively, as previously described (9, 11) . The merozygotic P pilD ::lacZ transcription reporter strain (RC176) was constructed from CMM2101, as described previously (9) . Using the same methodology, the merozygotic P pilD :: lacZ transcription reporter strain with a fur mutation (RC180) was newly constructed from CMM2304 for this study.
Culture conditions, growth and β-galactosidase activity measurements
To adapt V. vulnificus strains to iron-restricted conditions and to reduce intracellular iron storage, they were cultured for 12 h in HI broth containing 100 μM of the iron chelator α, α'-dipyridyl. These preconditioned strains were inoculated into iron-deficient broths or cirrhotic ascites at approxi- Effect of a fur mutation on the production of catechol-siderophore vulnibactin. The two P vvhA ::lacZ transcription reporter strains, CMM2103 with wild-type fur and CMM2305 with deleted fur, were cultured in iron-deficient Heart Infusion broths at 37℃ for 12 h. (A) Bacterial growth was measured by the optical density of culture aliquots at 600 nm (OD 600 ). (B) Culture supernatants were obtained by centrifugation and catechol concentration in the culture supernatants was determined by the Arnow test. Numeric values are expressed as the means ± standard deviation, from triplicate measurements. The # symbol indicates a statistically significant difference between the two means (p < 0.05 in Student's t-test).
RESULTS
Effect of a fur mutation on vulnibactin production
The effect of a fur mutation on production of the catechol-siderophore vulnibactin was determined using the V. vulnificus CMM2103 strain with wild-type fur and the V. vulnificus CMM2305 strain with deleted fur. The growth level of CMM2305 was higher than that of CMM2103 (Fig.   1A ). In the Arnow test, the production level of vulnibactin in CMM2103 was approximately 20 μM. In contrast, the production level of vulnibactin in CMM2305 was significantly increased compared with that in CMM2103 (Fig. 1B) .
Similar results were also observed when the production of vulnibactin between M06-24/O or CMM2101 and CMM-2304 was compared under similar conditions, as reported in our previous study (12) . These results indicate that a fur mutation stimulated V. vulnificus growth by de-repressing vulnibactin production in iron-limited in vitro conditions.
Effect of a fur mutation on vvhA expression and extracellular VvhA production and activity
The effects of a fur mutation on vvhA transcription and extracellular VvhA production were determined using CMM2103 with wild-type fur and CMM2305 with deleted fur. In the lacZ-fused transcription reporter assay, the vvhA expression level in CMM2305 was significantly increased compared to that of CMM2103 ( Fig. 2A) . In the tube hemolytic assay, extracellular VvhA activity in CMM2305 was significantly increased compared to that in CMM2103 (Fig. 2B) . In the dot blot analysis, the extracellular VvhA amount in CMM2305 was also significantly increased compared to that in CMM2103 (Fig. 2C) . These results indicate that a fur mutation increased extracellular VvhA production and activity by de-repressing vvhA expression under iron-limited in vitro conditions. A B Figure 2 . Effect of a fur mutation on vvhA expression and extracellular VvhA production and activity. The two P vvhA ::lacZ transcription reporter strains, CMM2103 with wild-type fur and CMM2305 with deleted fur, were cultured in iron-deficient Heart Infusion broths at 37℃ for 12 h. Bacterial growth was measured by the optical density of culture aliquots at 600 nm (OD 600 ), and culture supernatants were obtained by centrifugation. (A) The vvhA expression levels were measured by the Miller method and β-galactosidase activity was expressed as Miller units. (B) Extracellular VvhA activity was measured by the tube hemolytic assay using a 1% human red blood cell suspension. (C) Extracellular VvhA amount was determined by the dot blot method. For comparison on a per cell basis, signal intensities were quantified by densitometry. Numeric values are expressed as the means ± standard deviation, from triplicate measurements. The # symbol indicates a statistically significant difference between the two means (p < 0.05 in Student's t-test).
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Effect of a fur mutation on the activity of PilDmediated II GSS
The effect of a fur mutation on the activity of PilDmediated II-GSS responsible for extracellular VvhA secretion was determined by comparing pilD expression levels using the merozygotic P pilD ::lacZ transcription reporter strains, RC176 with wild-type fur and RC180 with mutated fur.
The growth level of RC180 was higher than that of RC176 (data not shown). In the β-galactosidase assay, the pilD transcription level in RC180 was significantly increased compared to that in RC176 (Fig. 3) . These results indicate that a fur mutation increased the PilD-mediated II-GSS activity in iron-limited in vitro conditions.
Easy inactivation of VvhA in cirrhotic ascites
To determine whether extracellular VvhA is easily inactivated in human body fluids while vvhA expression is de-repressed and maintained at high levels by a fur mutation, the merozygotic transcriptional reporter strains CMM2103 and CMM2305 were cultured in cirrhotic ascites. The growth level of CMM2305 was higher than that of CMM2103 (Fig. 4A) . In the β-galactosidase assay, the vvhA expression level in CMM2103 was severely repressed. In contrast, the vvhA expression level in CMM2305 increased significantly compared to that in CMM2103 (Fig. 4B) . In the dot blot analysis, the extracellular VvhA production level in CMM2305 increased significantly compared to that in CMM2103 (Fig. 4D) ; however, no extracellular VvhA activity was detected in either strain (Fig. 4C) . These results indicate that VvhA is easily inactivated in cirrhotic ascites while V. vulnificus growth is stimulated, vvhA expression is de-repressed, and extracellular VvhA production is increased by a fur mutation.
DISCUSSION
V. vulnificus often causes infections mainly in patients
with elevated serum or tissue iron levels such as hemochromatosis and hepatic diseases (18~20). Elevated iron levels are considered to be one of the most reliable predisposing factors by which to determine host susceptibility to V. vulnificus (21) . Our previous and present studies show that V. vulnificus growth is inhibited in cirrhotic ascites (8, 12) .
One of the reasons for this may be due to the fact that V. vulnificus is a ferrophilic bacterium which requires higher levels of available iron for growth than do other pathogenic bacteria (22) ; that is to say, cirrhotic ascites may be still an iron-limited condition for the ferrophilic bacterium V. The present study shows that a fur mutation can also facilitate extracellular VvhA production by increasing pilD expression. These findings suggest that a fur mutation may indirectly or secondarily affect pilD expression by increasing iron assimilation and eventually the intracellular iron level.
In cirrhotic ascites, de-repressed vvhA expression and facilitated extracellular VvhA secretion by a fur mutation can offer a simple useful means by which to measure the activity of VvhA in a setting where V. vulnificus growth, vvhA expression, and extracellular VvhA secretion are maintained at high levels. As described, V. vulnificus growth, vvhA expression, and extracellular VvhA secretion in cirrhotic ascites were all maintained at high levels by a fur mutation, but extracellular VvhA activity was not observed regardless of the presence or absence of a fur mutation. In contrast, extracellular VvhA activity in iron-deficient HI broths was significantly increased consistently with increased V. vulnificus growth, vvhA expression and extracellular VvhA production levels by the same fur mutation.
Our previous study revealed that vvhA expression is severely repressed in the presence of wild-type fur, even extracellular VvhA produced at very low levels is easily inactivated in cirrhotic ascites, and moreover, extracellular VvhA produced at high levels in HI broths is also inactivated in the presence of cirrhotic ascites. The present study shows more undeniable evidence that VvhA is easily inactivated in spite of being produced at high levels in cirrhotic ascites. It has been demonstrated that inactivation of VvhA in cirrhotic ascites is due to the self or cholesterolmediated oligomerization of VvhA and the interaction of VvhA with undefined constituents of cirrhotic ascites (8, 26) . In addition, the easy inactivation of VvhA provides a likely explanation of the pre-existing contradiction regarding the pathogenetic role of VvhA: vvhA mutations do not affect the virulence of V. vulnificus although purified VvhA is so potent that it can kill mice at low levels (2).
In conclusion, we were able to obtain more unequivocal evidence of the easy inactivation of VvhA in a human ex vivo experimental system by using a fur mutation which de-represses vvhA expression and increases extracellular VvhA production.
